Improved short-term cardiovascular profile after simultaneous pancreas-kidney transplantation;Evolución a corto plazo de los factores de riesgo cardiovascular tras el trasplante reno-pancreático

Nefrologia

Volumn 25, Issue 3, 2005, Pages 315-321

  Gonzalez Posada J M ^a,e   Perez Tamajon L ^a   Caballero, A ^b   Laynez, I ^c   Marrero, D ^a   Rodriguez C ^a   Bravo, A ^d   Meneses, M ^d   Alarco, A ^d   Morcillo, L ^b   Hernandez D ^a  

^a Servicio de Nefrologia

^b Servicio de Endocrinologia   (Argentina)

^c Servicio de Cardiología

^d Servicio de Cirugía General Y Digestivo

^e HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

Author keywords

Cardiovascular risk; Chronic renal failure; Diabetes mellitus; Simultaneous pancreas kidney transplantation

Indexed keywords

ANTIHYPERTENSIVE AGENT; GLYCOSYLATED HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; BLOOD; BODY MASS; CARDIOVASCULAR SYSTEM; CHRONIC KIDNEY FAILURE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; EVALUATION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION TEST; KIDNEY TRANSPLANTATION; MALE; PANCREAS TRANSPLANTATION; PATHOPHYSIOLOGY; PERITONEAL DIALYSIS; RENAL REPLACEMENT THERAPY; TREATMENT OUTCOME;

ADULT; ANTIHYPERTENSIVE AGENTS; BLOOD GLUCOSE; BODY MASS INDEX; CARDIOVASCULAR SYSTEM; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MALE; PANCREAS TRANSPLANTATION; PERITONEAL DIALYSIS; RENAL DIALYSIS; TREATMENT OUTCOME;

EID: 24944469655     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Becker BN, Brazy PC, Becker YT, Odorico JS, Pintar TJ, Collins BH, Pirsch JD, Leverson GE, Heisey DM, Sollinger HW: Simultaneous pancreas-kidney transplantation reduces excess mortality in type 1 diabetic patients with end-stage renal disease. Kidney Int 57: 2129-2135, 2000.
2. Ojo AO, Meier-Kriesche HU, Hanson JA, Leichtman A, Magee JC, Cibrik D, Wolfe RA, Port FK, Agodoa L, Kaufman DB, Kaplan B: The impact of simultaneous pancreas-kidney transplantation on long term patient survival. Transplantation 71: 82-90, 2001.
3. Executive Summary of the Third Report of the National Colesterol Educational Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholestero in Adults (Adult Treatment Panel III). JAMA 285: 2486-2496, 2001.
4. Chobanian AV, Bakris GL, Blak HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ: National Heart, Lung, and Blodd Institute Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: the JNC 7 Report. JAMA 289: 2560-72, 2003.
5. Khaw KT, Wareham N, Luben R, Bingham S, Oakes S, Welch A, Day N: Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk). BMJ 322: 1-6, 2001.
6. Fiorina P, La Roca E, Venturini M, Minicucci F, Fermo I, Paroni R, D'Angelo A, Sblendido M, Di Carlo V, Cristallo M, Del Maschio A, Pozza G, Secchi A: Effects of Kidney-Pancreas Transplantation on Atherosclerotic Risk Factors and Endotelial Function in Patients with Uremia and Type 1 Diabetes. Diabetes 50: 496-501, 2001.
7. La Roca E, Fiorina P, Di Carlo V, Astorri E, Rossetti C, Lucignani G, Fazio F, Giudici D, Cristallo M, Bianchi G, Poza G, Sechi A: Cardiovascular outcomes after kidney-pancreas and kidney-alone transplantation Kidney Int 60: 1964-1971, 2001.
8. Boots JM, Christiaans MH, Van Hooff JP: Effect of immunosuppressive agents on long-term survival of transplants recipients: focus on the cardiovascular risk. Drugs 64: 2047-73, 2004.
9. Foley RN, Parfrey PS, Sarnak MJ: Cardiovascular disease in chronic renal diseae. Clinical Epidemiology of Cardiovascular Disease in Chronic Renal Disease. Am J Kidney Dis 32 (Supl. 3): S112-S119, 1998.
10. Dimeny EM: Cardiovascular disease after renal transplantation. Kidney Int 61: S78-S84, 2002.
11. Ojo AO, Hanson JA, Wolfe RA, Agodoa LY, Leavey SF, Leitchman A, Young EW, Port FK: Long-term survival in renal transplant recipients with graft function. Kidney Int 57: 307-313, 2000.
12. Gill JS, Pereira BJG: Death in the first year after transplantation: implications for patients on the transplant waiting list. Transplantation 75: 113-117, 2003.
13. La Roca E, Fiorina P, Astorri E, Rossetti C, Lucignani G, Fazio F, Castoldi R, Bianchi G, Di Carlo V, Pozza G, Sechi A: Patient survival and cardiovascular events after kidney-pancreas transplantation: comparison with kidney transplantation alone in uremic IDDM patients. Cell Transplant 9: 929-932, 2000.
14. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW: Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement From the Americam Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108: 2154-2169, 2003.
15. Biesenbalch G, Margreiter R, Königsrainer A, Bösmüller C, Janko O, Brücke P, Gross C, Zazgornik J: Comparison of progression of macrovascular diseases after kidney or pancreas and kidney transplantation in diabetic patients with end-stage renal disease. Diabetología 42: 231-234, 2000.
16. Copelli A, Giannarelli R, Mariotti R, Rondinini L, Fossati N, Vistoli F, Aragona M, Rizzo G, Boggi U, Mosca F, Del Prato F, Marchetti P: Pancreas transplant alone determines early improvement of cardiovascular risk factors and cardiac function in Type 1 diabetic patients. Transplantation 76: 974-976, 2003.
17. The Diabetes Control and Complications Trial Research Group: The Effect of Intensive Treatment of Diabetes on the Development and Progression on Long-Term Complications in Insulin-Dependent Diabetes Mellitus. N Engl J Med 329: 977-986, 1993.
18. Nathan DM, Lachin J, Cleary P, Orchard T, Brillon DJ, Backlund JY, O'Leary DH, Genuth S: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Intensive Diabetes Therapy and Carotid Intima-Media Thickness in Type 1 Diabetes Mellitus. N Engl J Med 348: 2294-1303, 2003.
19. Moore R, Hernández D, Valantine H: Calcineurin Inhibitors and Post-Transplant Hyperlipaedemias. Drug Safety 24: 755-766, 2001.
20. Cosio FG, Pesavento TE, Pelletier RP, Henry M, Ferguson RM, Kim S, Lemeshow S: Patient Survival After Kidney Transplantation III: the Effects of Statins. Am J Kidney Dis 40: 638-643, 2002.